---
title: Optimus Drugs Private Limited vs Winkem Labs Pvt. Ltd.
slug_a: optimuspharma
slug_b: winkemlabs
site: cdmo
review_signal_gate: closed
canonical_path: /compare/optimuspharma/winkemlabs
---

# Optimus Drugs Private Limited vs Winkem Labs Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## Optimus Drugs Private Limited

- Profile: [/companies/optimuspharma](/companies/optimuspharma)

Optimus Drugs Private Limited — Leading CDMO delivering end-to-end small molecule drug substance and drug product development and manufacturing from clinical to commercial scale, with 21+ years of expertise and GMP-certified facilities.

Services: 11. Modalities: 1. Indications: 4. Locations: 1. Certifications: 4. The strongest documented coverage currently appears in services (11).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)

## Winkem Labs Pvt. Ltd.

- Profile: [/companies/winkemlabs](/companies/winkemlabs)

Winkem Labs Pvt. Ltd. — Contract development and manufacturing organization (CDMO) offering complex chemical synthesis, process development, API manufacturing, and supply services for pharmaceutical clients globally.

Services: 7. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Stainless Steel
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Cryogenic (−80 °C)